Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway
Related Experiment Video
Updated: Dec 8, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Bing Fei1, Zhibiao Liu1, Lisheng Xie1
1Department of Otolaryngology‑Head and Neck Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China.
Abstract:
Cisplatin‑induced cytotoxicity, such as nephrotoxicity, neurotoxicity and ototoxicity, restricts the clinical application of this compound. Panax notoginseng Saponins (PNS) exhibit potent free radical scavenging and antioxidant activity. PNS have been demonstrated to reduce cisplatin‑induced nephrotoxicity and neurotoxicity. The present study investigated the ability of PNS to protect the auditory HEI‑OC1 cell line against ototoxicity induced by cisplatin. PNS induced activation of the AKT/nuclear factor erythroid 2‑related factor 2 (Nrf2) signaling pathway. Following pretreatment with PNS, HEI‑OC1 cells were treated with cisplatin and cultured for 24 h. The viability of HEI‑OC1 cells was examined using a Cell Counting Kit‑8 assay. Double staining analysis was used to measure cell apoptosis. The ability of PNS to reduce reactive oxygen species (ROS) levels was assessed by flow cytometry. The levels of phosphorylated (p)‑AKT, heme oxygenase 1 (HO‑1), NAD(P)H quinone dehydrogenase 1 (NQO1), glutamate‑cysteine ligase catalytic (GCLC) and Nrf2 were measured by western blotting. HEI‑OC1 cells that were pretreated with PNS exhibited significantly increased cell viability compared with that noted in cells treated only with cisplatin. In addition, PNS suppressed the induction of apoptosis and ROS production following cisplatin treatment. The upregulation of NQO1, HO‑1 and GCLC expression in PNS‑pretreated cells was associated with p‑AKT levels and the activation of Nrf2. These findings suggested that PNS protected auditory cells against ototoxicity induced by cisplatin by activating AKT/Nrf2 signaling. PNS may serve as a potential candidate in regulating cisplatin‑induced cytotoxicity.
Insights
Panax notoginseng Saponins (PNS) protect auditory cells from cisplatin-induced ototoxicity by activating the AKT/Nrf2 pathway, reducing cell death and reactive oxygen species. This suggests PNS as a potential therapeutic agent against cisplatin side effects.
Area of Science:
- Pharmacology and Toxicology
- Cell Biology
- Oto-toxicology
Background:
- Cisplatin is a vital chemotherapeutic agent, but its clinical use is limited by severe toxicities, including ototoxicity.
- Panax notoginseng Saponins (PNS) possess antioxidant properties and have shown protective effects against cisplatin-induced nephrotoxicity and neurotoxicity.
- The potential of PNS to mitigate cisplatin-induced ototoxicity remains largely unexplored.
Purpose of the Study:
- To investigate the protective effects of Panax notoginseng Saponins (PNS) against cisplatin-induced ototoxicity in the HEI-OC1 auditory cell line.
- To elucidate the underlying molecular mechanisms, focusing on the AKT/nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.
Main Methods:
- HEI-OC1 cells were pretreated with PNS before exposure to cisplatin.
- Cell viability was assessed using the Cell Counting Kit-8 assay.
- Apoptosis, reactive oxygen species (ROS) levels, and the expression of key proteins (p-AKT, Nrf2, HO-1, NQO1, GCLC) were measured using double staining, flow cytometry, and western blotting.
Main Results:
- PNS pretreatment significantly enhanced HEI-OC1 cell viability compared to cisplatin-only treatment.
- PNS effectively suppressed cisplatin-induced apoptosis and ROS production.
- PNS upregulated the expression of NQO1, HO-1, and GCLC, correlating with increased p-AKT levels and Nrf2 activation.
Conclusions:
- Panax notoginseng Saponins (PNS) protect auditory cells from cisplatin-induced ototoxicity.
- The protective mechanism involves the activation of the AKT/Nrf2 signaling pathway, leading to reduced oxidative stress and apoptosis.
- PNS demonstrates potential as a therapeutic agent to mitigate cisplatin-induced ototoxicity.

